Theralase Announces Leadership Transition
TORONTO, ON / ACCESSWIRE / October 31, 2019 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage...
Day: October 31, 2019
Trxade Group Generates Record Revenues in Third Quarter of 2019
Revenue Growth of 173% to $2.311 Million Operating Income Growth of 94% to $177,853 7th straight quarter of positive operating...
NanoViricides Initiates Required Dermal Sensitization and Ocular Irritation Testing of Lead Drug Candidate towards IND
SHELTON, CT / ACCESSWIRE / October 31, 2019 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a company with novel platform...
Prolung, Inc. Presents Highest Combined Sensitivity And Specificity Values For A Truly Non-Invasive Lung Cancer Solution Pursuing FDA Clearance At ISRD & ATS Joint Medical Conference
SALT LAKE CITY, UT / ACCESSWIRE / October 31, 2019 / ProLung, Inc. ("ProLung" or the "Company") and its long-time...
Oncolytics Biotech(R) Provides Update on Partner Adlai Nortye’s Clinical Progress
Adlai received National Medical Products Administration approval for phase 3 clinical trials in China SAN DIEGO, CA and CALGARY, AB...
Alnylam Pharmaceuticals Reports Third Quarter 2019 Financial Results and Highlights Recent Period Activity
− Achieved Third Quarter 2019 ONPATTRO® Global Net Product Revenues of $46.1 Million, Including Initial Sales in Japan, with Over...
Masimo Announces CE Marking of Radius Capnography™ for the Root® Patient Monitoring and Connectivity Platform
Radius Capnography with Bluetooth® Connectivity Seamlessly Integrates Tetherless Mainstream Capnography on Root NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today that...